Satish Gopal

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. pmc Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
    Satish Gopal
    Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Natl Cancer Inst 105:1221-9. 2013
  2. pmc Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses
    Satish Gopal
    Institute of Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e70361. 2013
  3. doi request reprint Building a pathology laboratory in Malawi
    Satish Gopal
    Lancet Oncol 14:291-2. 2013
  4. pmc Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010
    Satish Gopal
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7305, USA
    AIDS Res Hum Retroviruses 28:798-805. 2012
  5. doi request reprint Meeting the challenge of hematologic malignancies in sub-Saharan Africa
    Satish Gopal
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7305, USA
    Blood 119:5078-87. 2012
  6. ncbi request reprint Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence
    Elizabeth L Yanik
    aUniversity of North Carolina, Chapel Hill, North Carolina bNorthwestern University, Chicago, Illinois cUniversity of Washington, Seattle, Washington dUniversity of Alabama, Birmingham, Alabama eJohns Hopkins University, Baltimore, Maryland fUniversity of California, San Diego gUniversity of California, San Francisco, California, USA
    AIDS 28:979-87. 2014
  7. pmc Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Infect Dis 57:756-64. 2013

Detail Information

Publications7

  1. pmc Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era
    Satish Gopal
    Departments of Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    J Natl Cancer Inst 105:1221-9. 2013
    ..Lymphoma is the leading cause of cancer-related death among HIV-infected patients in the antiretroviral therapy (ART) era...
  2. pmc Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnoses
    Satish Gopal
    Institute of Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America
    PLoS ONE 8:e70361. 2013
    ..Despite increasing cancer burden in Malawi, pathology services are limited. We describe operations during the first 20 months of a new pathology laboratory in Lilongwe, with emphasis on cancer diagnoses...
  3. doi request reprint Building a pathology laboratory in Malawi
    Satish Gopal
    Lancet Oncol 14:291-2. 2013
    ....
  4. pmc Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010
    Satish Gopal
    University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7305, USA
    AIDS Res Hum Retroviruses 28:798-805. 2012
    ....
  5. doi request reprint Meeting the challenge of hematologic malignancies in sub-Saharan Africa
    Satish Gopal
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7305, USA
    Blood 119:5078-87. 2012
    ..Achieving similar progress against hematologic cancers in sub-Saharan Africa will require the sustained collaboration and advocacy of the entire global cancer community...
  6. ncbi request reprint Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence
    Elizabeth L Yanik
    aUniversity of North Carolina, Chapel Hill, North Carolina bNorthwestern University, Chicago, Illinois cUniversity of Washington, Seattle, Washington dUniversity of Alabama, Birmingham, Alabama eJohns Hopkins University, Baltimore, Maryland fUniversity of California, San Diego gUniversity of California, San Francisco, California, USA
    AIDS 28:979-87. 2014
    ..To estimate the association between immunologic response to antiretroviral therapy (ART) and non-AIDS defining cancer (NADC) incidence in HIV-infected patients...
  7. pmc Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
    Elizabeth L Yanik
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
    Clin Infect Dis 57:756-64. 2013
    ..Cancer is an important cause of morbidity and mortality in individuals infected with human immunodeficiency virus (HIV), but patterns of cancer incidence after combination antiretroviral therapy (ART) initiation remain poorly characterized...